HMG-CoA reductase (HMGCR), the rate-limiting enzyme in cholesterol biosynthesis, is upregulated in HCC and is the target of statins, which regulate plasma cholesterol levels (50). Here, HMGCR is linked to hepatocellular carcinoma.